G. C. Pillai, F. Mentré, and J. L. Steimer, Non-Linear Mixed Effects Modeling ??? From Methodology and Software Development to Driving Implementation in Drug Development Science, Journal of Pharmacokinetics and Pharmacodynamics, vol.72, issue.6, pp.161-183, 2005.
DOI : 10.1007/s10928-005-0062-y

E. L. Plan, A. Maloney, F. Mentré, M. O. Karlsson, and J. Bertrand, Performance Comparison of Various Maximum Likelihood Nonlinear Mixed-Effects Estimation Methods for Dose???Response Models, The AAPS Journal, vol.14, issue.3, pp.420-432, 2012.
DOI : 10.1208/s12248-012-9349-2
URL : https://hal.archives-ouvertes.fr/inserm-00709829

L. Gibiansky, E. Gibiansky, and R. Bauer, Comparison of Nonmem 7.2 estimation methods and parallel processing efficiency on a target-mediated drug disposition model, Journal of Pharmacokinetics and Pharmacodynamics, vol.98, issue.1, pp.17-35, 2012.
DOI : 10.1007/s10928-011-9228-y

C. Bazzoli, S. Retout, and F. Mentré, Design evaluation and optimisation in multiple response nonlinear mixed effect models: PFIM 3.0, Computer Methods and Programs in Biomedicine, vol.98, issue.1, pp.55-65, 2010.
DOI : 10.1016/j.cmpb.2009.09.012
URL : https://hal.archives-ouvertes.fr/inserm-00431457

P. L. Bonate, Covariate Detection in Population Pharmacokinetics Using Partially Linear Mixed Effects Models, Pharmaceutical Research, vol.40, issue.4, pp.541-549, 2005.
DOI : 10.1007/s11095-005-2492-z

M. K. Al-banna, A. W. Kelman, and B. Whiting, Experimental design and efficient parameter estimation in population pharmacokinetics, Journal of Pharmacokinetics and Biopharmaceutics, vol.46, issue.4, pp.347-360, 1990.
DOI : 10.1007/BF01062273

S. Retout, F. Mentré, and R. Bruno, Fisher information matrix for non-linear mixed-effects models: evaluation and application for optimal design of enoxaparin population pharmacokinetics, Statistics in Medicine, vol.26, issue.6, pp.2623-2639, 2002.
DOI : 10.1002/sim.1041

B. Green and S. B. Duffull, Prospective Evaluation of a D-Optimal Designed Population Pharmacokinetic Study, Journal of Pharmacokinetics and Pharmacodynamics, vol.30, issue.2, pp.145-161, 2003.
DOI : 10.1023/A:1024467714170

F. P. Combes, S. Retout, N. Frey, and F. Mentré, Prediction of Shrinkage of Individual Parameters Using the Bayesian Information Matrix in Non-Linear Mixed Effect Models with Evaluation in Pharmacokinetics, Pharmaceutical Research, vol.78, issue.1???2, pp.2355-2367, 2013.
DOI : 10.1007/s11095-013-1079-3
URL : https://hal.archives-ouvertes.fr/inserm-00849820

Y. Merlé and F. Mentré, Bayesian design criteria: Computation, comparison, and application to a pharmacokinetic and a pharmacodynamic model, Journal of Pharmacokinetics and Biopharmaceutics, vol.19, issue.1, pp.101-125, 1995.
DOI : 10.1007/BF02353788

R. M. Savic and M. O. Karlsson, Importance of Shrinkage in Empirical Bayes Estimates for Diagnostics: Problems and Solutions, The AAPS Journal, vol.11, issue.3, pp.558-569, 2009.
DOI : 10.1208/s12248-009-9133-0

J. Bertrand and D. J. Balding, Multiple single nucleotide polymorphism analysis using penalized regression in nonlinear mixed-effect pharmacokinetic models, Pharmacogenetics and Genomics, vol.23, issue.3, pp.167-174, 2013.
DOI : 10.1097/FPC.0b013e32835dd22c

M. Liu, W. Lu, V. Krogh, G. Hallmans, T. V. Clendenen et al., Estimation and selection of complex covariate effects in pooled nested case-control studies with heterogeneity, Biostatistics, vol.14, issue.4, pp.682-694, 2013.
DOI : 10.1093/biostatistics/kxt015

J. Bertrand, E. Comets, C. M. Laffont, M. Chenel, and F. Mentré, Pharmacogenetics and population pharmacokinetics: impact of the design on three tests using the SAEM algorithm, Journal of Pharmacokinetics and Pharmacodynamics, vol.30, issue.4, pp.317-339, 2009.
DOI : 10.1007/s10928-009-9124-x
URL : https://hal.archives-ouvertes.fr/inserm-00406739

Z. Ge, P. J. Bickel, and J. A. Rice, An approximate likelihood approach to nonlinear mixed effects models via spline approximation, Computational Statistics & Data Analysis, vol.46, issue.4, pp.747-776, 2004.
DOI : 10.1016/j.csda.2003.10.011

P. Girard and F. Mentré, A comparison of estimation methods in nonlinear mixed effects models using a blind analysis. PAGE (Population Approach Group in Europe) 14, pp.16-17

C. Dartois, A. Lemenuel-diot, C. Laveille, B. Tranchand, M. Tod et al., Evaluation of Uncertainty Parameters Estimated by Different Population PK Software and Methods, Journal of Pharmacokinetics and Pharmacodynamics, vol.21, issue.3, pp.289-311, 2007.
DOI : 10.1007/s10928-006-9046-9

S. Ueckert, A. M. Johansson, E. L. Plan, A. Hooker, and M. O. Karlsson, New estimation methods in NONMEM 7: evaluation of robustness and runtimes, PAGE (Population Approach Group in Europe), vol.19, pp.8-11, 2010.

A. M. Johansson, S. Ueckert, E. L. Plan, A. Hooker, and M. O. Karlsson, New estimation methods in NONMEM 7: evaluation of bias and precision, PAGE (Population Approach Group in Europe), vol.19, pp.8-11, 2010.

X. S. Xu, M. Yuan, M. O. Karlsson, A. Dunne, P. Nandy et al., Shrinkage in Nonlinear Mixed-Effects Population Models: Quantification, Influencing Factors, and Impact, The AAPS Journal, vol.14, issue.4, pp.927-936, 2012.
DOI : 10.1208/s12248-012-9407-9

J. W. Mandema, D. Verotta, and L. B. Sheiner, Building population pharmacokineticpharmacodynamic models. I. Models for covariate effects, Journal of Pharmacokinetics and Biopharmaceutics, vol.19, issue.5, pp.511-528, 1992.
DOI : 10.1007/BF01061469

J. Ribbing, J. Nyberg, O. Caster, and E. N. Jonsson, The lasso???a novel method for predictive covariate model building in nonlinear mixed effects models, Journal of Pharmacokinetics and Pharmacodynamics, vol.32, issue.2, pp.485-517, 2007.
DOI : 10.1007/s10928-007-9057-1

J. Ribbing and E. N. Jonsson, Power, Selection Bias and Predictive Performance of the Population Pharmacokinetic Covariate Model, Journal of Pharmacokinetics and Pharmacodynamics, vol.31, issue.2, pp.109-134, 2004.
DOI : 10.1023/B:JOPA.0000034404.86036.72

F. Mentré, P. Burtin, Y. Merlé, J. Van-bree, A. Mallet et al., Sparse-Sampling Optimal Designs in Pharmacokinetics and Toxicokinetics, Therapeutic Innovation & Regulatory Science, vol.29, issue.3, pp.997-1019, 1995.
DOI : 10.1177/009286159502900321